Reckitt Benckiser Group PLC ADR (RBGLY)

Currency in USD
13.68
-0.14(-1.01%)
Delayed Data·
Earnings results expected in 7 days
High dividend Yield
RBGLY is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
13.6313.74
52 wk Range
12.2317.80
Key Statistics
Prev. Close
13.82
Open
13.74
Day's Range
13.63-13.74
52 wk Range
12.23-17.8
Volume
284.27K
Average Vol. (3m)
575.46K
1-Year Change
6.6958%
Book Value / Share
16.18
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
RBGLY Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Price Target
17.24
Upside
+26.02%
Members' Sentiments
Bearish
Bullish
ProTips
Has raised its dividend for 4 consecutive years
Show more

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Strong Sell
Moving Averages
Sell

Reckitt Benckiser Group plc manufactures and sells health, hygiene, and nutrition products in the United Kingdom and internationally. The company offers germ protection under Dettol name; intimate wellness under Durex and KY brand names; over the counter under the Biofreeze, Gaviscon, Mucinex, Nurofen, Delsym, Cepacol, and Strepsils names. It also provides personal care products under Clearasil and Veet brand names; vitamins, minerals, and supplements under MegaRed, Airborne, Digestive-Advantage, Movefree, and neuriva names; stain removal under Vanish brand name; and disinfectant products under the Finish, Harpic, and Lysol brands. In addition, the company offers nutritious complementary foods and milk formulas for infant and young children under the Enfamil and Nutramigen brands. Reckitt Benckiser Group plc was founded in 1819 and is headquartered in Slough, the United Kingdom.

Compare RBGLY to Peers and Sector

Metrics to compare
RBGLY
Peers
Sector
Relationship
P/E Ratio
10.2x21.5x12.0x
PEG Ratio
0.080.200.03
Price / Book
4.2x4.4x1.5x
Price / LTM Sales
2.3x2.2x0.9x
Upside (Analyst Target)
27.8%16.2%21.8%
Fair Value Upside
Unlock17.3%11.6%Unlock

Analyst Ratings

3 Buy
1 Hold
0 Sell
Ratings:
4 analysts
Overall Consensus
Buy

Analysts 12-Month Price Target:

Average 17.24
(+26.02% Upside)
Firm
ArticlePositionPrice TargetUpside / DownsideFrom Price TargetActionDate

Dividends

Payout Ratio
Payout ratio (TTM)
Earnings retained
EPS 4.89%
Dividend Yield
8.09%
Industry Median 2.81%
Annualized Payout
1.11
Paid unevenly
5-Years Growth
+3.13%
Growth Streak

Earnings

Latest Release
Mar 05, 2026
EPS / Forecast
-- / --
Revenue / Forecast
-- / 4.87B
EPS Revisions
Last 90 days

RBGLY Income Statement

People Also Watch

211.92
CAH
-1.41%
24.65
IVZ
-0.30%
60.08
MP
+4.74%
391.78
AVGO
+2.89%
27.04
SMCI
-0.61%

FAQ

What Is the Reckitt Benckiser ADR (RBGLY) Stock Price Today?

The Reckitt Benckiser ADR stock price today is 13.68 USD.

What Stock Exchange Does Reckitt Benckiser ADR Trade On?

Reckitt Benckiser ADR is listed and trades on the OTC Markets.

What Is the Stock Symbol for Reckitt Benckiser ADR?

The stock symbol for Reckitt Benckiser ADR is "RBGLY."

Does Reckitt Benckiser ADR Pay Dividends? What’s The Current Dividend Yield?

The Reckitt Benckiser ADR dividend yield is 8.02%.

What Is the Reckitt Benckiser ADR Market Cap?

As of today, Reckitt Benckiser ADR market cap is 43.92B USD.

What Is Reckitt Benckiser ADR's Earnings Per Share (TTM)?

The Reckitt Benckiser ADR EPS (TTM) is 4.89.

When Is the Next Reckitt Benckiser ADR Earnings Date?

Reckitt Benckiser ADR will release its next earnings report on Apr 22, 2026.

From a Technical Analysis Perspective, Is RBGLY a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.

How Many Times Has Reckitt Benckiser ADR Stock Split?

Reckitt Benckiser ADR has split 1 times.

How Many Employees Does Reckitt Benckiser ADR Have?

Reckitt Benckiser ADR has 36200 employees.

What is the current trading status of Reckitt Benckiser ADR (RBGLY)?

As of Apr 15, 2026, Reckitt Benckiser ADR (RBGLY) is trading at a price of 13.68 USD, with a previous close of 13.82 USD. The stock has fluctuated within a day range of 13.63 USD to 13.74 USD, while its 52-week range spans from 12.23 USD to 17.80 USD.

What Is Reckitt Benckiser ADR (RBGLY) Price Target According to Analysts?

The average 12-month price target for Reckitt Benckiser ADR is 17.24 USD, with a high estimate of 18.85314875 USD and a low estimate of 14.72991314 USD. 3 analysts recommend buying the stock, while 0 suggest selling, leading to an overall rating of Buy. The stock has an +26.02% Upside potential.

What Is the RBGLY Premarket Price?

RBGLY's last pre-market stock price is 13.74 USD. The pre-market share volume is 50.00, and the stock has decreased by -0.08, or -0.58%.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.